FI970696A - Oligonucleotide Conjugates, Compositions, and Methods for Degrading Ribonucleic Acids - Google Patents

Oligonucleotide Conjugates, Compositions, and Methods for Degrading Ribonucleic Acids Download PDF

Info

Publication number
FI970696A
FI970696A FI970696A FI970696A FI970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A
Authority
FI
Finland
Prior art keywords
compositions
methods
ribonucleic acids
oligonucleotide conjugates
degrading
Prior art date
Application number
FI970696A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970696A0 (en
Inventor
Dieter Huesken
Heinz Moser
Robert Haener
Jonathan Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970696A publication Critical patent/FI970696A/en
Publication of FI970696A0 publication Critical patent/FI970696A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI970696A 1994-09-02 1997-02-19 Oligonucleotide Conjugates, Compositions, and Methods for Degrading Ribonucleic Acids FI970696A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (en) 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids

Publications (2)

Publication Number Publication Date
FI970696A true FI970696A (en) 1997-02-19
FI970696A0 FI970696A0 (en) 1997-02-19

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970696A FI970696A0 (en) 1994-09-02 1997-02-19 Oligonucleotide Conjugates, Compositions, and Methods for Degrading Ribonucleic Acids

Country Status (8)

Country Link
EP (1) EP0778845A1 (en)
JP (1) JPH10505353A (en)
AU (1) AU3519095A (en)
CA (1) CA2197785A1 (en)
FI (1) FI970696A0 (en)
HU (1) HUT77034A (en)
NO (1) NO970885L (en)
WO (1) WO1996007667A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
WO1998007733A1 (en) * 1996-08-20 1998-02-26 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (en) * 2006-11-16 2011-06-10 주식회사 엘지화학 Purification method of terephthal aldehyde
US8084614B2 (en) 2007-04-06 2011-12-27 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
PE20090236A1 (en) 2007-04-06 2009-03-13 Neurocrine Biosciences Inc GONADOTROPIN RELEASING HORMONE RECEPTORS ANTAGONISTS AND PROCEDURES RELATED TO THEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
EP0778845A1 (en) 1997-06-18
AU3519095A (en) 1996-03-27
NO970885D0 (en) 1997-02-27
CA2197785A1 (en) 1996-03-14
HUT77034A (en) 1998-03-02
NO970885L (en) 1997-04-25
JPH10505353A (en) 1998-05-26
FI970696A0 (en) 1997-02-19
WO1996007667A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
AU2206800A (en) Targeted molecular bar codes and methods for using the same
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
DE69840172D1 (en) RNA EXPORTELEMENT
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
HK1031374A1 (en) Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives.
NL300150I2 (en) 4 "-substituted 9-deoxo-9A-AZA-9A-homoerythromycin-A derivatives.
AU4683099A (en) Targeted oligonucleotide conjugates
DE69503126D1 (en) REPETITIVE OLIGONUCLEOTIDE MATRIX
AU6876698A (en) File with sanitizing agent & method
AU2215995A (en) Freeze-dried compositions comprising rna
FI103704B1 (en) Antimicrobial composition, process for its preparation and its use
NO20000231D0 (en) Dolastatin-15 derivatives
DK0869121T3 (en) Hypolipidemic propanolamine derivatives
EE04311B1 (en) Azoles, process for their preparation, use as a pharmaceutical and pharmaceutical composition
FI972548A (en) Oligonucleotide dendrimerkonjugat
FI970696A (en) Oligonucleotide Conjugates, Compositions, and Methods for Degrading Ribonucleic Acids
EE200000129A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol, process for their preparation and use as pharmaceuticals
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
IL137162A0 (en) 2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors
IT238708Y1 (en) CRANKSET FOR FURNITURE.
FI933507A (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates for use as contrast agents and process for their preparation
HK1038363A1 (en) Phosphinous and phosphonic acid derivatives used as medicaments.
IT246279Y1 (en) CRANKSET FOR FURNITURE
FI933506A (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, method for their preparation and use as contrast agents